Abstract: A dielectric ceramic composition and a ceramic electric device having a dielectric layer composed of the dielectric ceramic composition including a main component having a perovskite crystal structure expressed by general formula ABO3, an oxide of Eu, an oxide of Ra (Sc, Er, Tm, Yb and Lu), an oxide of Rb (Y, Dy, Ho, Tb and Gd) and an oxide of Si, in which 0.075???0.5, 0.5???3, 1.0???4, 1.5???5, and 0.030??/??0.250 where a content of an oxide of Eu is ? mole, a content of the oxide of Ra is ? mole, a content of the oxide of Rb is ? mole, and a content of the second sub-component is ? mole with respect to 100 moles of the main component.

Abstract: A composite material that increases in temperature upon exposure to electromagnetic radiation includes single crystal silicon carbide whiskers and fibrils in a matrix material. Also disclosed are heat-generating objects that include the composite material, and a method of generating heat.

Abstract: Processes for manufacturing organic fertilizer products, such as liquid and solid organic fertilizer, from animal manure are disclosed, together with the fertilizer products produced therefrom.

Abstract: A system and method of recycling organic waste into biogas, implementing an anaerobic digestion processes, is disclosed. The system includes structural scaffolding and a pliable collapsible anaerobic digester. The aerobic digester includes at least one suspension tab, rendering the anaerobic digester suspendable from the structural scaffolding. A respective kit-of-parts is disclosed for assembling the aforementioned system.

Abstract: A modified fertilizer structure and a process for making the structure are disclosed. The structure contains at least a first modified oil layer that coats the fertilizer particle. Additional layers may be added as necessary to include a modified fiber layer that coats the modified oil layer, a second and third modified oil layers, a second modified fiber layer, a layer of diatomaceous earth mineral particles and a superabsorbent layer. The structure may be constructed by placing fertilizer particles in a rotating drum, then adding the materials for each layer consecutively into the drum at appropriate conditions. The modified fertilizer structure is configured to gradually release the nutrients into the soil over a desired period of time.

Abstract: A process for the conversion of oxygenates to olefins is presented. The process utilizes a catalyst having a 2-dimensional morphology, and the catalyst is a pentasil zeolite. The process is an oxygenate to olefins conversion under typical temperatures and pressures, but provides for an increased propylene yield and a reduced ethylene yield.

Abstract: A continuous flow process for the oligomerization of ethylene using a chromium catalyst having a phosphorus-nitrogen-phosphorus (“P—N—P”) ligand provides high selectivity to the desired tetramer (1-octene) with reduced production of coproduct C10+ oligomers. Prior art processes that maximize catalyst activity have provided comparatively poor product selectivity. In particular, the production of larger amounts of C10+ oligomers have been observed under conditions that maximize activity. The present process resolves this problem through the use of a combination of low catalyst concentration and by limiting the octene concentration in the reactor.

Abstract: Disclosed is a process for preparation of n-propyl benzene. The process gives high selectivity and yield of n-propyl benzene by single step catalytic alkylation that involves contacting a mixture of aromatic hydrocarbon having an active hydrogen on a saturated ?-carbon, such as toluene, and an alkene, such as ethylene, in presence of a metal catalyst, a solid support, and an initiator. Following the alkylation, aqueous and organic phases are separated from a reaction mixture. The aqueous phase is separated for recovery of the catalyst, the solid support, and un-reacted aromatic hydrocarbon (e.g., toluene); and the organic phase is separated for obtaining n-propyl benzene and byproduct. Thus, the catalyst phase can be recovered and recycled in the next alkylation reaction. Also, the process facilitates recovery and recycling of the byproduct for the better selectivity.

Abstract: A process for the production of jet and other heavy fuels, the process including: contacting at least one C3 to C5 isoalkanol with a first catalyst to convert at least a portion of the isoalkanol to isoalkene, isoalkene dimers, and water; contacting at least a portion of the isoalkene dimers with a second catalyst to convert at least a portion of the isoalkene dimers to isoalkene trimers; hydrotreating the isoalkene trimers to form isoalkanes useful as a jet fuel, kerosene, or other heavy fuels.

Abstract: Ethylene separation processes are described herein. The ethylene separation processes generally include introducing a feed stream including ethylene and butene into a de-ethenizer; and separating the ethylene from the butene via fractional distillation within the de-ethenizer to form an overhead stream including separated ethylene and a bottoms stream including separated butene, wherein the de-ethenizer operates at a pressure of less than 350 psig.

Abstract: The preparation of chlorinated hydrocarbons, such as pentachloropropanes, such as 1,1,1,2,3-pentachloropropane, from tetrachloropropanes, such as 1,1,1,3-tetrachloropropane, in the presence of a polyvalent antimony compound that includes a pentavalent antimony compound, such as antimony pentachloride, is described. Also described are methods for preparing optionally chlorinated alkenes, such as, tetrachloropropenes, from chlorinated alkanes, such as pentachloropropanes, in the presence of polyvalent antimony compound that includes a pentavalent antimony compound, as well as methods for recovering polyvalent antimony compounds from such processes.

Abstract: Techniques for synthesizing methanol are provided. In an exemplary embodiment, the processes include obtaining a syngas mixture from an integrated carbon dioxide hydrogenation process and a methane steam reforming process, and contacting the syngas mixture with a methanol catalyst to obtain a product stream comprising methanol.

Abstract: Providing a modified-graphene-like carbon material into which hydroxyl groups are introduced. By reacting a graphene-like carbon material with hydrogen peroxide, a hydroxyl group is introduced into the graphene-like carbon material.

Abstract: A scalable and sustainable process for production of renewable chemicals and biofuel from seaweed in its own juices or in seawater without desalination of the seaweeds is provided herein. The process as disclosed in the preset invention is an eco-friendly process for production of renewable chemicals and biofuel with an easy method of disposing of the waste streams. Further, the process as disclosed in the present invention is cost effective, suitable since transporting and storing the raw material obtained in the form of slurry of the seaweeds because of its lesser bulk is easy, easier handling due to its free flowing nature and its direct use for further processing to obtain renewable chemicals and/or biofuel.

Abstract: Disclosed are 2-methylene analogs of vitamin D3 and related compounds, their biological activities, and various pharmaceutical uses for these analogs. Particularly disclosed are 1?-hydroxy-2-methylene-vitamin D3, (20S)-1?-hydroxy-2-methylene-vitamin D3, and (5E)-1?,25-dihydroxy-2-methylene-vitamin D3, their biological activities, and various pharmaceutical uses for these compounds including methods of treating and/or preventing bone diseases and disorders.

Abstract: Provided is a method for producing aldehydes that brings an excellent alcohol conversion and aldehyde selectivity while suppressing generation of aldol condensates, etc. The method for producing aldehydes includes a step of dehydrogenating primary alcohol in the presence of a catalyst composition. The catalyst composition is a first catalyst composition obtained by adding a potassium salt of a weak acid to a dehydrogenation catalyst containing copper as an active species.

Abstract: A multi-reaction train hydroformylation process wherein a common product-catalyst separation zone is employed.

Abstract: A method for producing mixed aldol products from the products of hydroformylation reactions. In one embodiment, the method comprises mixing hydroformylation reaction products comprising aldehydes with a catalyst inside a reactor to create a mixture. The method also includes agitating the mixture at a temperature in a range of between about 200° F. to about 275° F. to create a reacted mixture. The reacted mixture is then cooled in the reactor to create an organic phase and an aqueous phase. The organic phase is pumped out of the reactor and may then be transferred to a distillation tower. The organic phase may be distilled until any mixed aldol products are isolated, wherein the mixed aldol products may be subsequently removed.

Abstract: In a process for improving a carbonylation process, iron is removed to maintain an effective Space Time Yield (STY) of the rhodium catalyst of at least 80% of the maximum STY. The process comprises carbonylating methanol in a reactor in a reaction medium comprising water, a rhodium catalyst, methyl iodide and a halide salt, separating a portion of the reaction medium in a flash vessel to form a less volatile stream and a vapor product stream comprising acetic acid, recycling a liquid stream to the reactor, wherein the liquid stream comprises a portion of the less volatile stream and wherein the liquid stream comprises iron, and removing a portion of the iron from the liquid stream to maintain an effective STY of the rhodium catalyst of at least 80% of the maximum STY.

Abstract: Process for preparing (meth)acrylates of the formula (I) CH2?C(R1)—CO—O—R2??(I) in which R1 is hydrogen or methyl and R2 is a saturated or unsaturated, linear or branched, aliphatic or cyclic alkyl radical having 6 to 22 carbon atoms, or a (C6-C14)-aryl-(C1-C8)-alkyl radical; by reacting a (meth)acrylate of the formula II CH2?C(R1)—CO—OR3??(II) with an alcohol of the formula (III) HO—R2??(III) in the presence of an amount of a suitable catalyst which catalyzes the reaction and of an amount of a phenolic polymerization inhibitor or a combination of two or more phenolic polymerization inhibitors which is sufficient to inhibit undesired polymerization; the reaction being undertaken with input or introduction into the reaction mixture resulting from the reaction of an amount of oxygen or of an oxygenous gas mixture sufficient to inhibit undesired polymerization, and the process is characterized in that the specific total oxygen input is less than or equal to 1.

Abstract: In a process for producing a methyl-substituted biphenyl compound, at least one methyl-substituted cyclohexylbenzene compound of the formula: wherein each of m and n is independently an integer from 1 to 3, is contacted with a dehydrogenation catalyst under conditions effective to produce a dehydrogenation reaction product comprising at least one methyl-substituted biphenyl compound. The dehydrogenation catalyst comprises an element or compound thereof from Group 10 of the Periodic Table of Elements deposited on a refractory support, such as alumina.

Abstract: Provided herein are methods that utilize polyhydroxyalkanoates (PHAs) as a substrate for further conversion to C4 and C5 compounds. Polyhydroxyalkanoates can undergo esterification to yield alkyl hydroxyalkanoates and alkyl alkenoates, which may serve as useful precursors in the production of alkadienes and alkenedioic acids, including for example butadiene and butenedioic acid.

Abstract: The invention relates to a compound of formula (1) The invention further relates to Pd complexes comprising the compound according to the invention and to the use thereof in alkoxycarbonylation.

Abstract: A corrosion-inhibiting composition includes a diluent and a mixture of organic salts of half ester-half acids of a dioic acid with of a glyceride group with a fatty acyl residue. Included are organic salts of glyceride-cyclic carboxylic acid anhydride adducts.

Abstract: Process for scrubbing a crude mixture which is obtained in the nitration of toluene after separating off the nitrating acid and comprises dinitrotoluene, nitric acid, nitrogen oxides and sulfuric acid, which comprises two scrubbing steps (WS-I) and (WS-II), wherein i) in a first scrubbing step (WS-I), the crude mixture is extracted with a scrubbing acid I comprising nitric acid, nitrogen oxides and sulfuric acid in a scrub comprising at least one extraction stage, where the scrubbing acid discharged from the first extraction stage (WS-I-1) of the first scrubbing step (WS-I) has a total acid content of from 10 to 40% by weight and a content of from 80 to 350 ppm of hydrocyanic acid, giving a prescrubbed crude mixture, ii) in a second scrubbing step (WS-II), the prescrubbed crude mixture comprising dinitrotoluene is extracted with a scrubbing acid II in a scrub comprising at least one, preferably at least 2, extraction stage(s), where the scrubbing acid discharged from the first extraction stage (WS-II-1) of th

Abstract: This disclosure relates to novel compounds containing an H2S releasing moiety and a nitric oxide (NO) releasing moiety covalently linked with a core (e.g., a salicylic acid moiety) and the use of such compounds in treating inflammatory diseases, including cancers. Therapeutic potency of these compounds is significantly higher than NSAIDs containing a H2S-releasing moiety alone (HS-NSAIDs) and NSAID containing a NO-releasing moiety alone (NO-NSAIDs). The compounds, in addition, exhibit reduced side effect, e.g., reduced stomach ulcers, upon administration.

Abstract: The present invention relates to novel pyrazole(thio)tetrahydronaphthyl carboxamides, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms in crop protection and in the protection of materials.

Abstract: A telescoping process for the preparation of 2-methoxymethyl-p-phenylenediamine, a cosmetically acceptable salt thereof, or mixture thereof. The process according to the present invention is a particularly cost effective process in that it avoids sophisticated chemical steps which requires special equipment or expensive catalysts and in that it comprises a recycling step of one of the starting materials, namely 2-hydroxymethylaniline.

Abstract: Provided is a new method for preparing (E)-3-(4-methoxyphenyl)-N-methyl-N-((6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)methyl)prop-2-en-1-amine as a drug intermediate.

Abstract: A method for producing a compound of formula (I) or a pharmaceutically acceptable salt, solvate, tautomer or stereoisomer, such as compound 1 and compound 2 is disclosed. The method proceeds through an O-allylated tyrosine-based compound, such as compound 3 and preferably comprises [3,3] sigmatropic Claisen rearrangement and olefin cross metathesis reactions. In addition, a pharmaceutical composition comprising a compound of formula (I) a tumor necrosis factor (TNF) related apoptosis inducing ligand (TRAIL) and a pharmaceutically acceptable carrier or excipient is disclosed.

Abstract: An object of the present invention is to provide a method for producing an optically active amino acid in high yield and in a highly enantioselective manner, which method has fewer restrictions on the material that can be used as the substrate, and to provide, among others, a compound useful as a chiral auxiliary for the method.

Abstract: The present invention relates to omegabalins, which are GABA derivatives of omega-3 fatty acids, and their use in pharmaceutically-acceptable formulations for treating neuropathic pain, fibromyalgia, epilepsy, anxiety, depression, insomnia, Alzheimer's disease, and other neurological conditions.

Abstract: An alternative acetylation process for the synthesis of 5-acetamido-N,N?-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (“Compound A”), an intermediate in the industrial preparation of non-ionic X-ray contrast agents, is described. The process can be performed on an industrial scale to produce Compound A with improved purity and improved yields compared to the established processes.

Abstract: The invention relates to compounds useful in treating conditions associated with voltage-gated ion channel function, particularly conditions associated with sodium channel activity. More specifically, the invention concerns compounds (e.g., compounds according to any of Formulas (I)-(XIII) or Compounds (1)-(236) of Table 1) that are useful in treatment of a variety of diseases and conditions.

Abstract: In one aspect, the invention relates to compounds having the formula: where R1-R5 and X are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.

Abstract: The present disclosure provides a photoreactive synthetic regulator of protein function. The present disclosure further provides a light-regulated polypeptide that includes a subject synthetic regulator. Also provided are cells and membranes comprising a subject light-regulated polypeptide. The present disclosure further provides methods of modulating protein function, involving use of light.

Abstract: Compounds of formula I are provided: R1 is an alkoxy or O(CH2)pX, p is an integer from 2 to 3 and X is OH, NH2, or CO2H, m is an integer from 0 to 5, n is an integer from 0 to 5, each R2 is independently selected from hydrogen, alkenyl, hydroxyalkyl, alkoxymethyl, heterocyclyl, hetereocyclylmethyl, amino, amido, hydroxamido, any of which may be optionally substituted with one or more of acyl, alkyl, alkoxy, hydroxyalkyl, or halogen, each R3 is independently selected from hydrogen, halogen, alkyl, alkenyl, carboxy, hydroxymethyl, amido, and at least one of R2 and R3 is not hydrogen.

Abstract: The present invention relates to a process for obtaining organic isocyanate from a phosgenation product comprising the isocyanate, comprising the following steps: a) workup to the phosgenation product, the workup comprising at least one distillation step in which a first portion of the organic isocyanate is removed as distillate and a distillation residue comprising a second portion of the organic isocyanate is obtained, b) workup of the distillation residue obtained in a), the workup comprising at least one distillation step which is conducted at a temperature of up to 110° C. at a pressure of not more than 1 mbar, wherein at least 50% by weight of the second portion of the organic isocyanate is removed from the distillation residue.

Abstract: The invention is directed to a method of treating fibromyalgia syndrome in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a process for preparing an internal olefin sulfonate, comprising sulfonating an internal olefin into sulfonated internal olefin followed by contacting sulfonated internal olefin with a base containing solution, wherein the molar ratio of internal olefin to solvent for the base is higher than 0.06. Further, the invention relates to an internal olefin sulfonate obtainable by said process.

Abstract: Provided is a 1-(2-acyloxyethyl)cyclopropyl sulfonate compound of General Formula (2): wherein R1 is a monovalent hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or more unsaturated bonds and Z is a monovalent hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or more unsaturated bonds.

Abstract: Provided herein are new processes for the preparation of aminosulfone intermediates for the synthesis of 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, which is useful for preventing or treating diseases or conditions related to an abnormally high level or activity of TNF-?. Further provided herein are processes for the commercial production of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine.

Abstract: Described herein is the DP2 antagonist 2-(3-(2-((tert-butylthio)methyl)-4-(2,2-dimethyl-propionylamino)phenoxy)-4-methoxyphenyl)acetic acid, or a pharmaceutically acceptable salt thereof. Also described are methods of preparing the DP2 antagonist, or a pharmaceutically acceptable salt thereof. Also described herein are pharmaceutical compositions suitable for administration to a mammal that include the DP2 antagonist, or a pharmaceutically acceptable salt thereof, and methods of using such pharmaceutical compositions for treating respiratory diseases or conditions, allergic diseases or conditions, inflammatory diseases or conditions, as well as other prostaglandin D2-dependent or prostaglandin D2-mediated diseases or conditions.

Abstract: The present invention refers to an amorphous form of a thiocolchicine derivative, IDN 5404, to a process for producing it and to pharmaceutical compositions thereof. The amorphous form is characterized by the XRPD pattern, DSC profile and/or TG/DTA profile.

Abstract: A process for converting light paraffins (especially C3-C5) to middle distillate and higher boiling range liquid hydrocarbons by (1) oxygen or air oxidation of iso-paraffins to alkyl hydroperoxides; (2) conversion of alkyl hydroperoxides to dialkyl peroxides; (3) radical coupling of paraffins using the dialkyl peroxides as radical initiators forming heavier hydrocarbon products; and (4) fractionation of the heavy hydrocarbon products. The net reaction is catalytically converting light paraffins to heavier hydrocarbons using oxygen or air to effect the conversion.

Abstract: Disclosed herein are compounds of formula (I) wherein L1, L2, L3, L4, R1, R4, R5, R6, and s are as defined in the specification. Compounds of formula (I) are EP4 agonists useful in the treatment of glaucoma, osteoporosis, bone fracture, periodontal bone loss, orthopedic implant, alopecia, neuropathic pain, and related disorders. Pharmaceutical compositions and methods of treating conditions or disorders are also described.

Abstract: This invention provides that (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid (captopril) possess potent in vitro urease inhibitory potential with 95.00% inhibition and IC50=16.6±1.52 ?M, when compared to the standard inhibitor i.e. acetohydroxamic acid (IC50=41.5±1.50 ?M).

Abstract: Disclosed are compounds of Formula (I): or a salt thereof, wherein: X is CR4 or N; R1, R2, R3, R4, and A are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

Abstract: 3,3?-Disubstituted indoline compounds, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.

Abstract: The present invention provides a new class of thermosetting ring-opening metathesis polymerization materials based on norbornene and oxanorbornene dicarboximide moieties containing at least one acetal ester group linkage. The acetal ester group is degradable when subjected to heat or acidic aqueous hydrolysis. The polymerization materials can be used in reworkable thermosetting compositions. R1-Rs, X, and n are defined herein.